Prices delayed by at least 15 minutes | Print
ChromaDex Corp (CDXC)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
Address
10900 Wilshire Boulevard
Suite 650
Los Angeles
CA
USA
90024
Telephone
+1 310 388-6706
Forecast key dates
Name | Key Date |
---|---|
ChromaDex Corp First Quarter Earnings Conference Call for 2025 | 2025-05-08T16:30:00 |
ChromaDex Corp First Quarter Earnings Results for 2025 | 2025-05-08T00:00:00 |
ChromaDex Corp Fourth Quarter Earnings Conference Call for 2024 | 2025-03-06T16:30:00 |
ChromaDex Corp Fourth Quarter Earnings Results for 2024 | 2025-03-06T00:00:00 |
ChromaDex Corp Annual Report for 2024 | 2025-03-06T00:00:00 |
ChromaDex Corp Third Quarter Earnings Conference Call for 2024 | 2024-11-08T16:30:00 |
ChromaDex Corp Third Quarter Earnings Results for 2024 | 2024-11-08T00:00:00 |
ChromaDex Corp Second Quarter Earnings Conference Call for 2024 | 2024-08-09T16:30:00 |
ChromaDex Corp Second Quarter Earnings Results for 2024 | 2024-08-09T00:00:00 |
ChromaDex Corp Annual General Meeting for 2024 | 2024-06-14T15:00:00 |
ChromaDex Corp First Quarter Earnings Conference Call for 2024 | 2024-05-08T16:30:00 |
ChromaDex Corp First Quarter Earnings Result for 2024 | 2024-05-08T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
ChromaDex Corp First Quarter Earnings Conference Call for 2024 | 2024-05-08T16:30:00 |
ChromaDex Corp First Quarter Earnings Result for 2024 | 2024-05-08T00:00:00 |
ChromaDex Corp Fourth Quarter Earnings Conference Call for 2023 | 2024-03-06T16:30:00 |
ChromaDex Corp Fourth Quarter Earnings Result for 2023 | 2024-03-06T00:00:00 |
ChromaDex Corp Annual Report for 2023 | 2024-03-06T00:00:00 |
ChromaDex Corp Third Quarter Earnings Conference Call for 2023 | 2023-11-08T16:30:00 |
ChromaDex Corp Third Quarter Earnings Result for 2023 | 2023-11-08T00:00:00 |
ChromaDex Corp Second Quarter Earnings Conference Call for 2023 | 2023-08-09T16:30:00 |
ChromaDex Corp Second Quarter Earnings Result for 2023 | 2023-08-09T00:00:00 |
ChromaDex Corp Annual General Meeting for 2023 | 2023-06-15T15:00:00 |
ChromaDex Corp First Quarter Earnings Conference Call for 2023 | 2023-05-10T16:30:00 |
ChromaDex Corp First Quarter Earnings Result for 2023 | 2023-05-10T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.